Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Audley, Bodurtha"'
Publikováno v:
Canadian Journal of Gastroenterology, Vol 6, Iss 2, Pp 84-86 (1992)
lnflammatory pseudotumours of the liver are rare, solid mass lesions (often mistaken for malignancy) and although inflammatory in nature, are obscure in etiology and pathogenesis. An hepatic inflammatory pseudotumour is presented in which cultures ob
Externí odkaz:
https://doaj.org/article/c64f6bf0c32448ff80b2654c8c9888d6
Autor:
Claire M. B. Holloway, Jim A. Julian, Mark Levine, Peter Lovrics, Nicole Hodgson, Ralph George, Kathleen I. Pritchard, Francisco Perera, Frances P. O'Malley, David R. McCready, Nancy Down, Audley Bodurtha, Leela Elavathil, W Shelley, Karen Y. Gulenchyn
Publikováno v:
Journal of Clinical Oncology. 30:1274-1279
Purpose 2-[18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) is potentially useful in assessing lymph nodes and detecting distant metastases in women with primary breast cancer. Patients and Methods Women diagnosed with operable breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca0fb754db0d2372829e06ccdecea5dd
https://doi.org/10.1200/jco.2011.38.1103
https://doi.org/10.1200/jco.2011.38.1103
Autor:
Vincent Young, William Steward, Nancy Wainman, Elizabeth Eisenhauer, Reinhard Lohmann, Karl Belanger, Ian Quirt, James J. Rusthoven, Audley Bodurtha
Publikováno v:
Investigational New Drugs. 20:431-437
To determine the tolerability and efficacy of daily oral marimastat (BB-2516 in patients with metastatic melanoma and to determine the matrix metalloproteinase (MMP) activity, tumour necrosis, peri- and intra-tumoral fibrosis and tumor inflammation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da908946e1717c9133d25d7ba3a0c73c
https://doi.org/10.1023/a:1020625423524
https://doi.org/10.1023/a:1020625423524
Autor:
Kathleen I, Pritchard, Jim A, Julian, Claire M B, Holloway, David, McCready, Karen Yvonne, Gulenchyn, Ralph, George, Nicole, Hodgson, Peter, Lovrics, Francisco, Perera, Leela, Elavathil, Frances P, O'Malley, Nancy, Down, Audley, Bodurtha, Wendy, Shelley, Mark N, Levine
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12)
2-[(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) is potentially useful in assessing lymph nodes and detecting distant metastases in women with primary breast cancer.Women diagnosed with operable breast cancer within 3 months under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7da6c840f0e062c8c018780223855c85
https://pubmed.ncbi.nlm.nih.gov/22393078
https://pubmed.ncbi.nlm.nih.gov/22393078
Publikováno v:
Annals of Oncology. 5:766-768
BACKGROUND Inoperable locally recurrent soft tissue sarcomas (STS) are incurable with chemotherapy. Therefore the National Cancer Institute of Canada Clinical Trials Group are performing phase II studies in an attempt to find better drugs. PATIENTS A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0e9e97f5487522a2c2d4518e72ac98c
https://doi.org/10.1093/oxfordjournals.annonc.a058985
https://doi.org/10.1093/oxfordjournals.annonc.a058985
Autor:
Elizabeth Eisenhauer, Shailendra Verma, Neill Iscoe, Audley Bodurtha, I. C. Quirt, V. J. Young, J. Davidson
Publikováno v:
Annals of Oncology. 4:254-255
Summary Background Phase I and II clinical trials have demonstrated acceptable toxicity and promising activity of Edatrexate (10-EDAM). The objective of this multicentre phase II study was to determine the efficacy and toxicity of this agent in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a1ba6a246c1bb91f59abfee132e00f0
https://doi.org/10.1093/oxfordjournals.annonc.a058467
https://doi.org/10.1093/oxfordjournals.annonc.a058467
Autor:
Peter McCulloch, Kathleen I. Pritchard, Ian G. Kerr, Neill Iscoe, Elizabeth Eisenhauer, Ian Quirt, Audley Bodurtha
Publikováno v:
Investigational new drugs. 3(3)
The National Cancer Institute of Canada Clinical Trials Group conducted a phase II study of spirogermanium given daily for 5 days every 3 weeks to previously untreated patients with malignant melanoma. In 21 evaluable patients one complete response w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a7253af405fc006276277c79d69155
https://pubmed.ncbi.nlm.nih.gov/4066224
https://pubmed.ncbi.nlm.nih.gov/4066224